Abstract
In Romania, more than 95% of patients present with advanced stage prostate cancer at the time of diagnosis. Our purpose was to detect early prostate cancer in the Romanian city of Oradea, with a screening based on digital rectal examination and fine needle aspiration biopsy. We performed digital rectal examinations on 701 men, between 50 to 80 years of age. Four men with a history of prostate cancer were excluded from the study. Transrectal fine-needle aspiration biopsies were done in 15 men who presented with suspicious findings at the digital rectal examination. Prostate cancer was cytologically proven in eleven men. Nine of these were low- to intermediate grade (GI-II) and clinically localized (T2). Two patients had clinical stage T3 tumors. The prostate cancer detection rate in the screened population was 1.6% (11/697). Currently, eight men have undergone total retropubic prostatectomy. One patient presented with pelvic lymph node metastases and, after a staging lymphadenectomy, only a bilateral orchiectomy was performed. This first Romanian mass screening study for prostate cancer revealed a great interest in early cancer detection among the general public. Continued effort to make asymptomatic men aware of the disease may ultimately lead to an overall stage reduction at the time of diagnosis in Romania.
Similar content being viewed by others
References
Landis SH, Murray T, Boldon S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8.
Post PN, Damhuis RAM, van der Meyden APM, EUROCARE Working Group. Variation in survival of patients with prostate cancer in Europe since 1978. Eur J Cancer 1998; 34: 2226.
Rietbergen JB, Hoedemaeker RF, Boeken Krueger AE et al. The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. J Urol 1999; 161: 1192.
Määttänen L, Auvinen A, Stenman UH et al. European randomized study of prostate cancer screening: first results of the Finnish trial. Br J Cancer 1999; 79: 1210.
DeAntoni EP. Eight years of “prostate cancer awareness week”. Cancer 1997; 80: 1845.
Smart CR. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program. Cancer 1997; 80: 1835.
Schröder FH, Kranse R, Rietbergen J et al. The European randomized study of screening for prostate cancer (ERSPC): an update. Eur Urol 1999; 35: 539.
Fran'en S, Giertz G, Zajicek J. Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. Br J Urol 1960; 32: 193.
Esposti PL. Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. A five-year follow-up study of 649 hormone-treated patients. Scand J Urol Nephrol 1971; 5(3): 199.
Sobin L, Wittekind C (eds). TNM Classification of Malignant Tumours, 5 edn. New York: J Wiley and Sons, 1997: 225.
Brawer MK, Chetner MP, Beatie J et al. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992; 147: 841.
Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283.
Horninger W, Reissigl A, Rogatsch H et al. Prostate cancer screening in Tyrol, Austria: experience and results. Fur Urol 1999; 35: 523.
Chodak G, Schoenberg HW. Early detection of prostate cancer by routine screening. JAMA 1984; 252: 3261.
Littrup PJ, Goodman AC, Mettlin CJ. The benefit and cost of prostate cancer early detection. The investigators of the American Cancer Society-National Prostate Cancer Detection Project. CA Cancer J Clin 1993; 43: 134.
Thompson JM, Rounder JB, Teague JL et al. Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urol 1987; 137: 424.
Jacobsen SJ, Bergstralh EJ, Katusic SK et al. Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology 1998; 52: 173.
Gann PH, Hennekens CH, Stamper MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995; 273: 289.
Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery - what we have learned and where are going. J Urol 1999; 162: 293.
Ljung B-M, Cherrie R, Kaufman JJ. Fine needle aspiration biopsy of the prostate gland: a study of 103 cases with histological follow up. J Urol 1986; 135: 955.
Andersson L, Hagmar B, Ljung B-M, Skoog L. Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Scand J Urol Nephrol Suppl 1994; 162: 43.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Waidelich, R., Bumbu, G., Raica, M. et al. Screening for prostate cancer in Romania. Int Urol Nephrol 34, 503–505 (2002). https://doi.org/10.1023/A:1025627204632
Issue Date:
DOI: https://doi.org/10.1023/A:1025627204632